Anti-nicotinic properties of anticholinergic antiparkinson drugs

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 11, 1998, Pages 1299-1305

  Gao, Z G ^a   Liu, B Y ^a   Cui, W Y ^a   Li, L J ^a   Fan, Q H ^a   Liu, C G ^a,b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; ARECOLINE; ATROPINE; BENZATROPINE; BIPERIDEN; CARAMIPHEN; MECAMYLAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; PROCYCLIDINE; PROFENAMINE; TRIHEXYPHENIDYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RAT; TREMOR;

EID: 0031731640     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03349.x     Document Type: Article

References (25)

1. Ascher, P., Large, W. A., Rang, H. P. (1979) Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J. Physiol. 295: 139-170
2. 3H]Mecamylamine binding to brain membranes, studies with mecamylamine and nicotine analogues. Biochem. Pharmacol. 40: 2105-2110
3. Collins, A. C., Evan, C. B., Miner, L. L., Marks, M. J. (1986) Mecamylamine blockade of nicotine response: evidence for two brain nicotinic receptors. Pharmacol. Biochem. Behav. 24: 1767-1773
4. Gao, Z. G., Liu, C. G. (1995) Competitive and allosteric binding of 2α-DHET and its optical isomers to rat cardiac muscarinic receptors. Eur. J. Pharmacol. 289: 369-373
5. Gao, Z. G., Wang, L., Liu, C. G., Zhang, Q. K. (1995a) Effects of a new cholinolytic drug of tropanes and its optical isomers on central muscarinic and nicotinic receptors. Pharmacol. Res. 32: 105-109
6. Gao, Z. G., Wang, L., Liu, C. G. (1995b) Effects of 2α-DHET and its optical isomers on muscarinic and nicotinic receptors. Life Sci. 56: PL461-PL466
7. Gao, Z. G., Cui, W. Y., Wang, L., Liu, C. G. (1996a) Pharmacological activity and receptor binding characteristics of 2β-(2′,2′-phenylcyclopentyl-2′-hydroxyethoxy)tropane and its optical isomers. Arch. Int. Pharmacodyn. 331: 124-135
8. Gao, Z. G., Wang, L., Liu, C. G. (1996b) Allosteric and competitive interactions of 2α-(2′,2′-disubstituted-hydroxy-ethoxy)tropane and its optical isomers to rat central muscarinic acetylcholine receptors. Life Sci. 58: 2279-2287
9. Gao, Z. G., Cui, W. Y., Liu, B. Y., Liu, C. G., Wang, L. (1997) Anticholinergic activity in mice and receptor-binding properties in rats of a series of synthetic tropane derivatives. J. Pharm. Pharmacol. 49: 315-318
10. Lipiello, P. M., Fernandes, K. G. (1988) Identification of putative high-affinity nicotinic receptors on cultured cortical neurons. J. Pharmacol. Exp. Ther. 246: 409-416
11. 3H]nicotine binding in rat cortex. Neuropharmacology 32: 847-853
12. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
13. Marks, M. J., Romm, E., Gaffney, D. K., Collins, A. C. (1986) Nicotine-induced tolerance and receptor changes in four mouse strains. J. Pharmacol. Exp. Ther. 237: 809-819
14. Martin, B. R. (1986) Nicotine receptors in the central nervous system. In: Conn, P. (ed.) The Receptors. Vol. III, Academic Press, New York, pp 393-415
15. Martin, B. R., Onaivi, E. S., Martin, J. (1989) What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem. Pharmacol. 38: 3391-3397
16. Martin, T. J., Suchocki, J., May, E. L., Martin, B. R. (1990) Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine. J. Pharmacol. Exp. Ther. 254: 45-51
17. Niu. W. Z., Zhao, D. L., Liu, C. G. (1990) The effects of a new cholinolytic-8018-and its optical isomers on central muscarinic and nicotinic receptors. Arch. Int. Pharmacodyn. 304: 64-74
18. 3H]acetylcholine in rat brain. Mol. Pharmacol. 22: 56-62
19. 3H]nicotine binding to mouse brain homogenate. J. Pharm. Pharmacol. 40: 793-797
20. Stolerman, I. P., Pratt, J. A., Garcha, H. S., Giardini, V., Kumar, R. (1983) Nicotine cue in rats analyzed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22: 1029-1037
21. Takayama, H., Majewska, M. D., London, E. D. (1989) Interactions of non-competitive inhibitors with nicotinic receptors in the rat brain. J. Pharmacol. Exp. Ther. 253: 1083-1089
22. Trendelenburg, U. (1961) Observations on the mode of action of some non-depolarizing ganglion-blocking substances. Arch. Exp. Pathol. Pharmacol. 241: 452-466
23. van Rossum, J. M. (1962) Classification and molecular pharmacology of ganglionic blocking agents. Part II. Mode of action of competitive and noncompetitive ganglionic agents. Int. J. Neuropharmacol. 1: 403-421
24. Wonnacott, S. (1990) Characterization of nicotine receptor sites in the brain. In: Wonnacott, S., Russel, M. A. H., Stolerman, I. P. (eds) Nicotine Psychopharmacology. Oxford University Press, Oxford, pp 226-277
25. Zhang, Y. N., Liu, C. G. (1996) Muscarinic and nicotinic components of electroencephalogram seizure discharges induced by soman and physostigmine in rats. Chin. J. Pharmacol. Toxicol. 10: 101-108